Clinical trial
Radiation Therapy or Temozolomide in Treating Patients With Gliomas
NCT00182819 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00182819 |
|---|---|
| Title | Radiation Therapy or Temozolomide in Treating Patients With Gliomas |
| Official title | Primary Chemotherapy With Temozolomide Versus Radiotherapy in Patients With Low Grade Gliomas After Stratification for Genetic 1p Loss: A Phase III Study |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Collaborators | NCIC Clinical Trials Group British Medical Research Council Trans Tasman Radiation Oncology Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Radiation |
| Interventions | temozolomide, radiation therapy |
| Enrollment | 709 |
| Start date | Jul 1, 2005 |
| Primary completion | Aug 1, 2013 |
| Completion | May 1, 2014 |
| First posted | Sep 16, 2005 |
| Last update posted | Oct 12, 2016 |
| Countries | Australia, Austria, Belgium, Canada, Egypt, France, Germany, Hungary, Israel, Italy, Luxembourg, Netherlands and 7 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: